Angiotensin II Antagonists in Patients with Connective Tissue Diseases

Abstract

Get full access to this article

View all access options for this article.

References

Meyer

Atherosclerosis and connective tissue diseases. Joint Bone Spine 2001;68:564–75.

Esdaile

Abrahamowicz

Grodzicky

Panaritis

du Berger

Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 2001;44:2331–7.

Weber

KT.

Angiotensin II and connective tissue: Homeostasis and reciprocal regulation. Regul Pept 1999;82:1–17.

Dziadzio

Denton

Smith

Howell

Blann

Bowers

Losartan therapy for Raynaud's phenomenon and scleroderma: Clinical and biochemical findings in a fifteen-week, randomized, parallel-group, controlled trial. Arthritis Rheum 1999;42:2646–55.

Lewanczuk

Daneshtalab

Russell

Jamali

Effects of inflammation on a model of cytochrome p450 dependent versus independent antihypertensives: Losartan versus valsartan (abstract). Am J Hypertens 2002;15:228A.